Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Cu-Uvin

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Plos One|June 12, 2014
Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS)Staci L Sudenga, Howard W Wiener, Caroline C King, et al.
Journal of the International AIDS Society|June 12, 2023
Predictors of PrEP awareness, PrEP discussion and interest in long-acting injectable PrEP among Filipina transfeminine adultsArjee Javellana Restar, Ma Irene Quilantang, Jeffrey Wickersham, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
The Journal of Infectious Diseases|February 17, 2018
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN StudyErna Milunka Kojic, Lois Conley, Tim Bush, et al.
Plos One|June 8, 2012
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tractTimothy Lahey, Mimi Ghosh, John V Fahey, et al.
American Journal of Epidemiology|June 16, 2006
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative womenJill Koshiol, Jane Schroeder, Denise J Jamieson, et al.
AIDS (London, England)|January 25, 2002
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cellsMarie Larsson, David T Wilkens, Jean-François Fonteneau, et al.
International Journal of Cancer|April 29, 2006
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatusJill E Koshiol, Jane C Schroeder, Denise J Jamieson, et al.
AIDS Research and Human Retroviruses|September 3, 2025
Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African WomenHlengiwe P Madlala, Landon Myer, Hayli Geffen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2014
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected womenErna Milunka Kojic, Minhee Kang, Michelle S Cespedes, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Plos One|June 12, 2014
Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS)Staci L Sudenga, Howard W Wiener, Caroline C King, et al.
Journal of the International AIDS Society|June 12, 2023
Predictors of PrEP awareness, PrEP discussion and interest in long-acting injectable PrEP among Filipina transfeminine adultsArjee Javellana Restar, Ma Irene Quilantang, Jeffrey Wickersham, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
The Journal of Infectious Diseases|February 17, 2018
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN StudyErna Milunka Kojic, Lois Conley, Tim Bush, et al.
Plos One|June 8, 2012
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tractTimothy Lahey, Mimi Ghosh, John V Fahey, et al.
American Journal of Epidemiology|June 16, 2006
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative womenJill Koshiol, Jane Schroeder, Denise J Jamieson, et al.
AIDS (London, England)|January 25, 2002
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cellsMarie Larsson, David T Wilkens, Jean-François Fonteneau, et al.
International Journal of Cancer|April 29, 2006
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatusJill E Koshiol, Jane C Schroeder, Denise J Jamieson, et al.
AIDS Research and Human Retroviruses|September 3, 2025
Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African WomenHlengiwe P Madlala, Landon Myer, Hayli Geffen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2014
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected womenErna Milunka Kojic, Minhee Kang, Michelle S Cespedes, et al.
Pageof 14